• ACR, physician groups warn HHS against new pricing proposals for biologics

    6 monthes ago - By Healio

    The American College of Rheumatology has joined eight other national physician groups in calling on HHS to reconsider a series of new drug pricing proposals, including one that would consolidate some medications covered under Medicare Part B into Medicare Part D, warning they could increase costs and limit access for patients.
    In a letter to HHS Secretary Alex M. Azar II, the groups, including the American Academy of Neurology, the American Academy of Opthalmology and the American Urological Association, also warned against a proposal that would reduce physician reimbursements for new drugs
    Read more ...